Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and cefixime treatment of typhoid in South Asia
ISRCTN18065452Phase 4Completed
- Sponsor
- University of Oxford
- Start
- May 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in typhoid fever, paratyphoid fever and enteric fever comparing Azithromycin + cefixime with Azithromycin + cefixime-matched placebo (2 arms). Primary endpoints: Composite treatment failure by day 28, Clinical failure and 1 more. Started May 2021; status: completed.
02
Drugs
azithromycincefixime
03
Conditions
typhoid feverparatyphoid feverenteric fever
Beyond the preview
Go deeper on ISRCTN18065452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18065452.